PACERR
gene geneOn this page
Also known as PACERPTGS2-AS1
Summary
PACERR (PTGS2 antisense NFKB1 complex-mediated expression regulator RNA, HGNC:50552) is a long non-coding RNA gene on chromosome 1q31.1.
This gene represents transcription of a long non-coding RNA produced in antisense to the prostaglandin-endoperoxide synthase 2 (PTGS2) gene. This transcript interacts with NF-kB transcriptional regulators to promote expression of PTGS2.
Source: NCBI Gene 103752588 — RefSeq curated summary.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:50552 |
| Approved symbol | PACERR |
| Name | PTGS2 antisense NFKB1 complex-mediated expression regulator RNA |
| Location | 1q31.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | PACER, PTGS2-AS1 |
| Ensembl gene | ENSG00000273129 |
| Ensembl biotype | lncRNA |
| OMIM | 617650 |
| Entrez | 103752588 |
| RNAcentral | URS00007E42F7 — lncRNA, 793 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 lncRNA
ENST00000608917
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000608917 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004219548 | 186680108 | 186683165 |
Expression profiles
Bgee: expression breadth ubiquitous, 118 present calls, max score 73.71.
FANTOM5 (CAGE): breadth broad, TPM avg 2.4273 / max 181.5289, expressed in 592 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 7367 | 1.3034 | 377 |
| 7366 | 0.6074 | 183 |
| 7368 | 0.3762 | 141 |
| 7365 | 0.1403 | 48 |
Top tissues by expression
118 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bone marrow cell | CL:0002092 | 73.71 | gold quality |
| prostate gland | UBERON:0002367 | 69.30 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 68.79 | gold quality |
| right uterine tube | UBERON:0001302 | 68.65 | gold quality |
| urinary bladder | UBERON:0001255 | 66.54 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 65.94 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 65.62 | gold quality |
| granulocyte | CL:0000094 | 65.58 | gold quality |
| right coronary artery | UBERON:0001625 | 65.42 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 64.93 | gold quality |
| lower esophagus | UBERON:0013473 | 64.88 | gold quality |
| popliteal artery | UBERON:0002250 | 64.82 | gold quality |
| tibial artery | UBERON:0007610 | 64.77 | gold quality |
| left coronary artery | UBERON:0001626 | 64.65 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 64.47 | gold quality |
| fundus of stomach | UBERON:0001160 | 63.32 | gold quality |
| endocervix | UBERON:0000458 | 62.65 | gold quality |
| bone marrow | UBERON:0002371 | 61.78 | gold quality |
| colon | UBERON:0001155 | 61.34 | gold quality |
| ectocervix | UBERON:0012249 | 61.17 | gold quality |
| vagina | UBERON:0000996 | 60.83 | gold quality |
| gall bladder | UBERON:0002110 | 60.20 | gold quality |
| right atrium auricular region | UBERON:0006631 | 60.16 | gold quality |
| ascending aorta | UBERON:0001496 | 60.06 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 59.48 | gold quality |
| thoracic aorta | UBERON:0001515 | 59.45 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 59.40 | gold quality |
| metanephros cortex | UBERON:0010533 | 59.39 | gold quality |
| leukocyte | CL:0000738 | 59.23 | gold quality |
| myometrium | UBERON:0001296 | 58.93 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.64 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 5)
- Findings suggest that P50-associated COX-2 extragenic RNA (PACER) promotes proliferation and metastasis of osteosarcoma cells by activating the cyclooxygenase-2 (COX-2) gene and its own expression was influenced by DNA methylation. (PMID:26476537)
- Therefore, lncRNA PACER is down-regulated in OA and regulates chondrocyte apoptosis by down-regulating lncRNA HOTAIR. (PMID:31113870)
- PACER lncRNA regulates COX-2 expression in lung cancer cells. (PMID:35136486)
- LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma. (PMID:35526050)
- Expression profile of long-noncoding RNAs MIR31HG, NKILA, and PACER in systemic lupus erythematosus patients. (PMID:38395324)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.